12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

ImaginAb, Lundbeck deal

Antibody company ImaginAb partnered with H. Lundbeck to reengineer an antibody against an undisclosed CNS target from...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >